Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation

Maroun M Abou-Jaoude; Imad Ghantous; Wassim Y Almawi

Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation

Maroun M Abou-Jaoude, Imad Ghantous, Wassim Y Almawi

Department of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1083-1088
Number of pages	6
Journal	Molecular Immunology
Volume	39
Issue number	17-18
Publication status	Published - 2003

Cite this

@article{575fa3d5777746b0a5857f808ed7a589,

title = "Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation",

author = "Abou-Jaoude, {Maroun M} and Imad Ghantous and Almawi, {Wassim Y}",

year = "2003",

language = "English",

volume = "39",

pages = "1083--1088",

journal = "Immunochemistry",

issn = "0161-5890",

publisher = "Elsevier",

number = "17-18",

}